machine learning
The preprint raised concerns about the findings of a 2020 cancer microbiome study that spurred the development of a microbiome-based liquid biopsy test for cancer.
The firm has a handful of beta users of the assay design tool but has not previously publicly disclosed its strategy to make the method broadly available.
Pathomiq, Neuberg Diagnostics Partner to Launch Prostate Cancer Recurrence Test
The companies aim to first introduce the machine learning-based test, which analyzes histopathology slides to predict prostate cancer relapse and metastasis, in the US.
Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout
Premium
Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types.
Companies that built their business in tissue and blood-based DNA analyses are now exploring imaging technologies across a variety of fronts.